RU2006133521A - PHARMACEUTICAL COMPOSITION FOR INHALATION - Google Patents

PHARMACEUTICAL COMPOSITION FOR INHALATION Download PDF

Info

Publication number
RU2006133521A
RU2006133521A RU2006133521/152006133521/15A RU2006133521A RU2006133521A RU 2006133521 A RU2006133521 A RU 2006133521A RU 2006133521 A RU2006133521 A RU 2006133521A RU 2006133521 A RU2006133521 A RU 2006133521A
Authority
RU
Russia
Prior art keywords
active substance
inhalation
pharmaceutical composition
biologically active
particles
Prior art date
Application number
RU2006133521/152006133521/15A
Other languages
Russian (ru)
Other versions
RU2338552C2 (en
Inventor
ВлаНебольсин Владимир Евгеньедимир Евгеньевич Небольсин (RU)вич (RU)
Владимир Евгеньевич Небольсин
АлексЧучалин Александр Григорьеандр Григорьевич Чучалин (RU)вич (RU)
Александр Григорьевич Чучалин
ЕвгБабарсков Евгений Викторовений Викторович Бабарсков (RU)ич (RU)
Евгений Викторович Бабарсков
ГалЖелтухина Галина Александрина Александровна Желтухина (RU)овна (RU)
Галина Александровна Желтухина
ВиолКовалева Виолетта Леонидоветта Леонидовна Ковалева (RU)на (RU)
Виолетта Леонидовна Ковалева
Original Assignee
ВлаНебольсин Владимир Евгеньедимир Евгеньевич Небольсин (RU)вич (RU)
Владимир Евгеньевич Небольсин
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ВлаНебольсин Владимир Евгеньедимир Евгеньевич Небольсин (RU)вич (RU), Владимир Евгеньевич Небольсин filed Critical ВлаНебольсин Владимир Евгеньедимир Евгеньевич Небольсин (RU)вич (RU)
Priority to RU2006133521/15A priority Critical patent/RU2338552C2/en
Priority to PCT/RU2007/000506 priority patent/WO2008036003A1/en
Priority to EA200900464A priority patent/EA016363B1/en
Publication of RU2006133521A publication Critical patent/RU2006133521A/en
Application granted granted Critical
Publication of RU2338552C2 publication Critical patent/RU2338552C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Фармацевтическая композиция для ингаляции, включающая тонкодисперсное биологически активное вещество в виде частиц респирабельных размеров и грубодисперсный биологически инертный носитель в виде частиц нереспирабельных размеров, отличающаяся тем, что биологически активное вещество включает глутарилгистамин при следующем соотношении ингредиентов, мас.%:A pharmaceutical composition for inhalation, comprising a finely dispersed biologically active substance in the form of particles of respirable size and a coarse biologically inert carrier in the form of particles of non-respirable sizes, characterized in that the biologically active substance includes glutaryl histamine in the following ratio of ingredients, wt.%:

Claims (1)

Фармацевтическая композиция для ингаляции, включающая тонкодисперсное биологически активное вещество в виде частиц респирабельных размеров и грубодисперсный биологически инертный носитель в виде частиц нереспирабельных размеров, отличающаяся тем, что биологически активное вещество включает глутарилгистамин при следующем соотношении ингредиентов, мас.%:A pharmaceutical composition for inhalation, comprising a finely dispersed biologically active substance in the form of particles of respirable size and a coarse biologically inert carrier in the form of particles of non-respirable sizes, characterized in that the biologically active substance includes glutaryl histamine in the following ratio of ingredients, wt.%: Биологически активное веществоBiologically active substance 1-501-50 Биологически инертный носительBiologically Inert Carrier остальноеrest
RU2006133521/15A 2006-09-19 2006-09-19 Pharmaceutical composition for inhalation RU2338552C2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU2006133521/15A RU2338552C2 (en) 2006-09-19 2006-09-19 Pharmaceutical composition for inhalation
PCT/RU2007/000506 WO2008036003A1 (en) 2006-09-19 2007-09-19 Pharmaceutical inhalation composition
EA200900464A EA016363B1 (en) 2006-09-19 2007-09-19 Pharmaceutical inhalation composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006133521/15A RU2338552C2 (en) 2006-09-19 2006-09-19 Pharmaceutical composition for inhalation

Publications (2)

Publication Number Publication Date
RU2006133521A true RU2006133521A (en) 2008-03-27
RU2338552C2 RU2338552C2 (en) 2008-11-20

Family

ID=39200744

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006133521/15A RU2338552C2 (en) 2006-09-19 2006-09-19 Pharmaceutical composition for inhalation

Country Status (3)

Country Link
EA (1) EA016363B1 (en)
RU (1) RU2338552C2 (en)
WO (1) WO2008036003A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9504673B2 (en) 2009-05-21 2016-11-29 LTD “Valenta-Intellekt” Agent for the prophylaxis and treatment of highly pathogenic infectious diseases
UA115431C2 (en) * 2011-10-11 2017-11-10 Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" Use of glutaryl histamine to treat respiratory tract infections
RU2518314C2 (en) * 2012-08-30 2014-06-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Method and agent activating irf-3 for treating and preventing diseases caused by (+) rna containing viruses
CN103382179A (en) * 2013-06-05 2013-11-06 四川百利药业有限责任公司 Ingavirin polymorph and its preparation method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ303154B6 (en) * 1998-11-13 2012-05-09 Jagotec Ag Dry powder formulation for inhalation containing magnesium stearate

Also Published As

Publication number Publication date
WO2008036003A1 (en) 2008-03-27
EA200900464A1 (en) 2009-10-30
RU2338552C2 (en) 2008-11-20
EA016363B1 (en) 2012-04-30

Similar Documents

Publication Publication Date Title
MXPA05012278A (en) Compositions for delivering peptide yy and pyy agonists.
RU2009116832A (en) COMPOSITION INCLUDING ARBIDOL IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES
RU2006133521A (en) PHARMACEUTICAL COMPOSITION FOR INHALATION
EA200801614A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MONTELUKAST
RU2007112670A (en) MEDICINAL PREVENTIVE MEANS
RU2006125572A (en) COMPOSITION FOR PREPARATION OF A BIOLOGICALLY ACTIVE ADDITIVE FOR FOOD
RU2008113403A (en) DRUG FOR PROCESSING ORGANIC WASTE "ECOS"
MX2008002272A (en) Cyclopropyl compounds and compositions for delivering active agents.
RU2009141290A (en) ANTI-INFLAMMATORY WELL-HEALING AGENT
RU2007112331A (en) PHARMACEUTICAL COMPOSITION BASED ON SIGETINE
UY27674A1 (en) POWDER INHALATION PRODUCT CONTAINING THE CGRP ANTAGONIST, BIBN4096, AND PROCEDURE FOR PREPARATION.
RU2008142115A (en) BIOLOGICALLY ACTIVE COMPOSITION
RU2006105913A (en) PRODUCT OF STABILIZED OZONE
RU2006125570A (en) COMPOSITION FOR PREPARATION OF A BIOLOGICALLY ACTIVE ADDITIVE FOR FOOD
RU2004111888A (en) DRUG FOR TREATMENT AND PREVENTION OF BACTERIAL-MUSHROOM INFECTIONS IN ANIMALS
RU2005109113A (en) VOLCANIZATION ACCELERATOR
RU2004125222A (en) MEAN "KAFFA DIET" ("KAFFA DIET") FOR SLIMMING
RU2006111665A (en) ANTIOXIDANT COMPOSITION BASED ON LITHIUM ascorbate
RU2009101087A (en) THE PRODUCT CONTAINING BIOLOGICALLY ACTIVE ACTIVE SUBSTANCES
RU2004117841A (en) COMBINED DRUG WITH SEDED, SPASMOLITIC AND ANTI-ALLERGIC ACTION
RU2006100478A (en) POLYMER COMPOSITION
RU2006107356A (en) COMPOSITE NANOSIZED MATERIAL FOR ADSORPTION AND DESORPTION OF DNA / RNA
RU2006118853A (en) VISUAL IMPROVEMENT AGENT
RU2005104596A (en) MEDICINE
RU2004126303A (en) WEAR-RESISTANT FOAM MATERIAL

Legal Events

Date Code Title Description
FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20080226

MM4A The patent is invalid due to non-payment of fees

Effective date: 20090920